Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 1813 (117th)

Accelerating Access to Critical Therapies for ALS Act

referredUnited States· United States Congress· EN

Introduced

25 May 2021

Last action

25 May 2021 · Introduced

Status

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

Sen. Coons, Christopher A. [D-DE], Sen. Murkowski, Lisa [R-AK], Sen. King, Angus S., Jr. [I-ME], Sen. Boozman, John [R-AR], Sen. Shaheen, Jeanne [D-NH], Sen. Capito, Shelley Moore [R-WV], Sen. Bennet, Michael F. [D-CO], Sen. Manchin, Joe, III [D-WV], Sen. Sinema, Kyrsten [I-AZ], Sen. Leahy, Patrick J. [D-VT], Sen. Feinstein, Dianne [D-CA], Sen. Kelly, Mark [D-AZ], Sen. Padilla, Alex [D-CA], Sen. Tester, Jon [D-MT], Sen. Hoeven, John [R-ND], Sen. Marshall, Roger [R-KS], Sen. Rosen, Jacky [D-NV], Sen. Inhofe, James M. [R-OK], Sen. Blumenthal, Richard [D-CT], Sen. Gillibrand, Kirsten E. [D-NY], Sen. Murphy, Christopher [D-CT], Sen. Schatz, Brian [D-HI], Sen. Casey, Robert P., Jr. [D-PA], Sen. Moran, Jerry [R-KS], Sen. Markey, Edward J. [D-MA], Sen. Collins, Susan M. [R-ME], Sen. Thune, John [R-SD], Sen. Warren, Elizabeth [D-MA], Sen. Durbin, Richard J. [D-IL], Sen. Sullivan, Dan [R-AK], Sen. Klobuchar, Amy [D-MN], Sen. Stabenow, Debbie [D-MI], Sen. Van Hollen, Chris [D-MD], Sen. Cortez Masto, Catherine [D-NV], Sen. Smith, Tina [D-MN], Sen. Peters, Gary C. [D-MI], Sen. Hassan, Margaret Wood [D-NH], Sen. Hirono, Mazie K. [D-HI], Sen. Brown, Sherrod [D-OH], Sen. Blunt, Roy [R-MO], Sen. Luján, Ben Ray [D-NM], Sen. Baldwin, Tammy [D-WI], Sen. Whitehouse, Sheldon [D-RI], Sen. Carper, Thomas R. [D-DE], Sen. Cassidy, Bill [R-LA], Sen. Barrasso, John [R-WY], Sen. Lummis, Cynthia M. [R-WY], Sen. Merkley, Jeff [D-OR]

Subjects

Healthcare, Education

Source updated

5 December 2025

Healthcare · Education

Summary

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities to facilitate patients' access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other severely debilitating neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 25 May 2021

    Introduced

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Source: IntroReferral

  2. 25 May 2021

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 25 May 2021

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 25 May 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 25 May 2021

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 65 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.